RxDoctor Payments Data

Aaron Smith, MD

Anesthesiology · Salt Lake City, UTNPI 1033614821

Payments from drug & device makers

What this record shows

12 manufacturers reported payments, led by Abbott at 55.1% of the total. Reporting peaked in 2023 at $4,762 and has fallen 87.3% since, to $604 in 2025. Among anesthesiology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,826in general payments, 2019–2025

Across 124 payments — averaging $63.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • Medtronic$1K
  • Nevro Corp.$485
  • Boston Scientific$452
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$398
  • Collegium Pharmaceutical, Inc.$275
  • plus $512 from 6 others

What the payments were for

  • Travel & lodging$4,51358%
  • Food & beverage$3,31442%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,826 in reported general payments places this provider in the 95th percentile of 510 anesthesiology providers in Utah.

See all anesthesiology providers in Utah

Medicare billing

Part B allowed, 2024
$355,561
Medicare patients
325
Services billed
2,511

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl13$10,943
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen165$7,731
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen184$6,507
Oxycodone Hcl211$5,778
Buprenorphine25$5,500
Fentanyl29$3,837
Morphine Sulfate ErMorphine Sulfate59$1,620
Pregabalin83$1,512
Hydromorphone Hcl40$1,493
Tramadol Hcl108$1,435
Gabapentin71$1,394
Methadone Hcl41$1,084
Trazodone Hcl31$1,002
Buprenorphine Hcl38$955
Carisoprodol43$592

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →